Cutimed^® Sorbact^® Hydroactive B

is a hydrophobic bacteria binding, absorbent gel dressing with an adhesive border. Cutimed^® Sorbact^® Hydroactive B combines a highly absorbent hydropolymer matrix, that balances absorption and hydration, with hydrophobic bacteria binding Sorbact^® technology. It is covered by a semipermeable polyurethane film. The hydrogel fixation border does not contain a natural rubber latex.

For use in infection wound management
Safe removal of hydrophobic bacteria
Effective against most common resistant pathogens

Intended Purpose

Indications: Cutimed® Sorbact® Hydroactive B is indicated for use in the management of low to moderate exudating partial to full thickness wounds (including clean, colonized, contaminated, or infected wounds): chronic wounds (venous and arterial ulcers, diabetic foot ulcers and pressure injuries), postoperative dehisced wounds and traumatic wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 4 days.

Learn about the products' mode of action

Product benefits

Symbol of a shield representing infection prevention

For use in infection wound management

Sorbact® Technology dressings reduce bioburden and support effective wound healing, with low risk of allergies^{1, 2, 3, 4, 5, 6}.

Symbol of looped threads to visualize the term 'pacify'

Safe removal of hydrophobic bacteria

Sorbact® Technology dressings irreversibly bind and remove adhered hydrophobic bacteria⁵, without the release of active agents to the wound. Development of bacterial resistance is not expected.

Effective against most common resistant pathogens

In vitro tests show that Sorbact® Technology dressings are able to inhibit the growth of the Top 5 WHO pathogens⁷.

Maintains a moist wound environment

Helps to maintain a moist wound environment and supports moist wound healing.

Symbol showing the gentlest method of cleaning wounds

Supports autolytic debridement

Autolytic debridement faciliates the wound healing process.

Product facts

Superficial

Infected

Sloughy

Low to moderate

How to use

Usage instruction for Cutimed Hydroactive B

1. Clean the wound per appropriate clinical protocol.
2. Select an appropriate dressing according to wound size. For best results, make sure Cutimed® Sorbact® Hydroactive B overlaps the wound margins by at least 2 cm.
3. Remove the protective film and apply the green adhesive side of the dressing to the wound.
4. Depending on the wound location it may be appropriate to apply additional dressing fixation.
5. Cutimed® Sorbact® Hydroactive B should be changed as often as dictated by the wound condition. As with all absorbent dressings, monitoring is required to ensure the dressing does not dry out and adhere to the wound. The dressing should be changed when it becomes cloudy or opaque from fluid absorption. At the latest after 4 days or if the exudate has reached 1 cm from the edge.
6. In wounds that show signs of clinical infection, a more frequent wound inspection is advised. In these cases, an appropriate systemic treatment should be considered.

Product specifications

PRODUCT	REF	Dimensions	Wound pad size	Pieces/box
Cutimed^® Sorbact^® Hydroactive B	7993300	3 in x 3.5 in	2 in x 2.5 in	10
Cutimed^® Sorbact^® Hydroactive B	7993302	5.5 in x 5.5 in	4 in x 4 in	10
Cutimed^® Sorbact^® Hydroactive B	7993303	7.5 in x 7.5 in	6 in x 6 in	10
Cutimed^® Sorbact^® Hydroactive B	7993304	5.5 in x 9.5 in	4 in x 8 in	10

Medical References

¹ Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.

² Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.

³ Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.

⁴ Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.

⁵ Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.

⁶ Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.

⁷ Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).